La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

UpHealth Dividendo

Dividendo criteri di controllo 0/6

UpHealth non ha registrato alcun pagamento di dividendi.

Informazioni chiave

n/a

Rendimento del dividendo

n/a

Rapporto di remunerazione

Rendimento medio del settore	1.1%
Prossima data di pagamento dei dividendi	n/a
Data di stacco del dividendo	n/a
Dividendo per azione	n/a
Utile per azione	-US$2.93
Previsione del rendimento del dividendo	n/a

Aggiornamenti recenti sui dividendi

Nessun aggiornamento

Recent updates

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Dati insufficienti per determinare se i dividendi per azione di UPHL siano rimasti stabili in passato.

Dividendo in crescita: Dati insufficienti per determinare se i pagamenti dei dividendi di UPHL siano aumentati.

Rendimento dei dividendi rispetto al mercato

UpHealth Rendimento dei dividendi rispetto al mercato

Come si colloca il rendimento da dividendo di UPHL rispetto al mercato?
Segmento	Rendimento dei dividendi
Azienda (UPHL)	n/a
Fondo del 25% del mercato (US)	1.4%
Top 25% del mercato (US)	4.3%
Media del settore (Healthcare Services)	1.1%
Previsione dell'analista in 3 anni (UPHL)	n/a

Dividendo notevole: Impossibile valutare il rendimento dei dividendi di UPHL rispetto al 25% inferiore dei pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Dividendo elevato: Impossibile valutare il rendimento dei dividendi di UPHL rispetto al 25% dei maggiori pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Distribuzione degli utili agli azionisti

Copertura degli utili: Dati insufficienti per calcolare il payout ratio di UPHL per determinare se i suoi pagamenti di dividendi sono coperti dagli utili.

Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Impossibile calcolare la sostenibilità dei dividendi poiché UPHL non ha segnalato alcun pagamento.

UpHealth Dividendo

Dividendo criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sui dividendi

Recent updates

UpHealth, Inc. announced delayed 10-Q filing

UpHealth, Inc. announced delayed 10-Q filing

UpHealth, Inc. announced delayed annual 10-K filing

GTCR LLC completed the acquisition of Cloudbreak Health, LLC from UpHealth, Inc. (NYSE:UPH).

NYSE Grants UpHealth's Request for A Hearing Before the CFR

Uphealth, Inc. Elects James Greene as Director

NYSE Regulation Determines to Commence Proceedings to Delist the UpHealth's Common Stock

NYSE Regulation Determines to Commence Proceedings to Delist the UpHealth's Common Stock

UpHealth, Inc., Annual General Meeting, Dec 27, 2023

UpHealth, Inc. Reports Impairment of Goodwill, Intangible Assets, and Other Long-Lived Assets for the Third Quarter Ended September 30, 2023

GTCR LLC entered into a membership interests purchase agreement to acquire Cloudbreak Health, LLC from UpHealth, Inc. (NYSE:UPH) for approximately $180 million.

GTCR LLC entered into a membership interests purchase agreement to acquire Cloudbreak Health, LLC from UpHealth, Inc. (NYSE:UPH) for approximately $180 million.

UpHealth, Inc. announced delayed 10-Q filing

Uphealth, Inc. Announces CFO Changes

Uphealth, Inc. Announces Board Changes

UpHealth, Inc.(NYSE:UPH) dropped from S&P TMI Index

Price target increased by 11% to US$7.02

Consensus EPS estimates fall by 30%, revenue upgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

UpHealth, Inc. Revises Earnings Guidance for the Year 2023

UpHealth, Inc. to Report Q2, 2023 Results on Aug 10, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

UpHealth, Inc. to Report Q1, 2023 Results on May 11, 2023

Full year 2022 earnings: EPS misses analyst expectations

Analysts Just Shaved Their UpHealth, Inc. (NYSE:UPH) Forecasts Dramatically

Consensus revenue estimates fall by 11%

Full year 2022 earnings: EPS misses analyst expectations

High number of new and inexperienced directors

UpHealth, Inc., Announces Resignation of Ramesh Balakrishnan as President and Chief Strategy Officer

UpHealth FQ3 revenue misses

UpHealth, Inc. Appoints Timothy Wilde as Chief Technology Officer

UpHealth says reverse stock split to effect changes to warrant terms

Uphealth, Inc. Announces Executive Appointments

UpHealth, Inc., Annual General Meeting, Dec 05, 2022

UpHealth, Inc. announced delayed 10-Q filing

Uphealth Inc. Announces Appointment of Melissa Frieswick, as Chief Growth Officer

Uphealth, Inc. Appoints Mahesh Inder Veer Singh as Executive Vice President

Consensus EPS estimates fall by 25%

UpHealth, Inc. announced that it has received $67.5 million in funding

UpHealth: The SPAC Disaster 'Du Jour'

Price target decreased to US$3.50

No longer forecast to breakeven

UpHealth Q2 2022 Earnings Preview

UpHealth Provides Information to Shareholders

UpHealth, Inc Announces Board Changes

UpHealth, Inc. Appoints Samuel J. Meckey as Chief Executive Officer

Jeffery Bray Provides Information to Shareholders of UpHealth Inc

Jeffery R. Bray Sends an Email to Shareholders of UpHealth

UpHealth Inc Communicates with Shareholders

UpHealth, Inc. Announces Board Changes

Mariya Pylypiv Discloses its Views on UpHealth

UpHealth, Inc. Appoints Daniel Mandoli as Executive Vice President of U.S. Services, Effective June 13, 2022

UpHealth: Troubled Virtual Healthcare Provider Still Searching For Answers

UpHealth Receives Non-Compliance Notice from NYSE

UpHealth, Inc. announced delayed 10-Q filing

UpHealth Announces Samuel J. Meckey as Chief Executive Officer, Effective July 2022

UpHealth, Inc. Provides Unaudited Earnings Guidance for the Year Ended December 31, 2022

UpHealth, Inc., Annual General Meeting, Jun 28, 2022

UpHealth, Inc. announced delayed annual 10-K filing

These Analysts Think UpHealth, Inc.'s (NYSE:UPH) Sales Are Under Threat

UpHealth, Inc. Provides Earnings Guidance for the Full Year 2022

UpHealth, Inc. Releases Martti™ Translation, Expanding Language Access Offering

UpHealth Is A Great Bargain At These Levels

Co-Founder recently bought US$102k worth of stock

Why UpHealth Has 300% Upside

Forecast to breakeven in 2023

UpHealth: Interesting But Difficult To Value

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Stabilità e crescita dei pagamenti

Rendimento dei dividendi rispetto al mercato

Distribuzione degli utili agli azionisti

Pagamenti in contanti agli azionisti

Scoprire le società che pagano dividendi forti